Drug Prices In Ads Could Cause Sticker Shock For Consumers, Forcing Pharma To Tinker With Marketing Strategies

Experts don't predict the proposed requirement would cause a broad pullback of ad campaigns, but companies will have to make some tough, and possibly expensive, choices. Meanwhile, President Donald Trump hints at a big win for drugmakers with a big change to Medicaid's rebate rule.

from Kaiser Health News https://ift.tt/2RYMixG